184 related articles for article (PubMed ID: 25145501)
1. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
2. T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center.
Rottoli M; Stocchi L; Dietz DW
Ann Surg Oncol; 2012 Aug; 19(8):2500-5. PubMed ID: 22395999
[TBL] [Abstract][Full Text] [Related]
3. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer.
Chu QD; Zhou M; Medeiros K; Peddi P
Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043
[TBL] [Abstract][Full Text] [Related]
4. Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer.
Shimizu H; Kuriu Y; Arita T; Kiuchi J; Yamamoto Y; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
World J Surg; 2021 May; 45(5):1561-1568. PubMed ID: 33538878
[TBL] [Abstract][Full Text] [Related]
5. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
[TBL] [Abstract][Full Text] [Related]
6. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
[TBL] [Abstract][Full Text] [Related]
7. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
[TBL] [Abstract][Full Text] [Related]
11. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
14. Is the prognosis of T1-2N1 colon cancer the same as that of T1-2N0 colon cancer after curative surgery?
Pian G; Oh SY
Scand J Gastroenterol; 2023; 58(11):1286-1294. PubMed ID: 37345584
[No Abstract] [Full Text] [Related]
15. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
Kim HS; Kim KM; Lee SB; Kim GR; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2019 Sep; 120(3):423-430. PubMed ID: 31134644
[TBL] [Abstract][Full Text] [Related]
17. Association of Radial Margin Positivity With Colon Cancer.
Amri R; Bordeianou LG; Sylla P; Berger DL
JAMA Surg; 2015 Sep; 150(9):890-8. PubMed ID: 26132363
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
19. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL; Sargent DJ; Tepper JE; O'Connell MJ; Allmer C; Smalley SR; Martenson JA; Haller DG; Mayer RJ; Rich TA; Ajani JA; Macdonald JS; Goldberg RM
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):386-96. PubMed ID: 12243812
[TBL] [Abstract][Full Text] [Related]
20. Revised TN categorization for colon cancer based on national survival outcomes data.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart AK
J Clin Oncol; 2010 Jan; 28(2):264-71. PubMed ID: 19949014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
